cilostazol

Generic: cilostazol

Labeler: apotex corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cilostazol
Generic Name cilostazol
Labeler apotex corp.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cilostazol 50 mg/1

Manufacturer
Apotex Corp.

Identifiers & Regulatory

Product NDC 60505-2521
Product ID 60505-2521_855689c6-1a9b-a366-dcc4-e6a1c04ff25a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077030
Listing Expiration 2026-12-31
Marketing Start 2011-10-18

Pharmacologic Class

Established (EPC)
phosphodiesterase 3 inhibitor [epc]
Mechanism of Action
phosphodiesterase 3 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605052521
Hyphenated Format 60505-2521

Supplemental Identifiers

RxCUI
242461 242462
UPC
0360505252213
UNII
N7Z035406B
NUI
N0000175598 N0000175086

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cilostazol (source: ndc)
Generic Name cilostazol (source: ndc)
Application Number ANDA077030 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (60505-2521-1)
  • 30 TABLET in 1 BOTTLE (60505-2521-3)
  • 1000 TABLET in 1 BOTTLE (60505-2521-8)
source: ndc

Packages (3)

60505-2521-1 60 TABLET in 1 BOTTLE (60505-2521-1) 60505-2521-3 30 TABLET in 1 BOTTLE (60505-2521-3) 60505-2521-8 1000 TABLET in 1 BOTTLE (60505-2521-8)

Ingredients (1)

cilostazol (50 mg/1)

Linked Drug Pages (1)

cilostazol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "855689c6-1a9b-a366-dcc4-e6a1c04ff25a", "openfda": {"nui": ["N0000175598", "N0000175086"], "upc": ["0360505252213"], "unii": ["N7Z035406B"], "rxcui": ["242461", "242462"], "spl_set_id": ["ceac1ae3-c343-28ca-c083-b748d21a15e6"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (60505-2521-1)", "package_ndc": "60505-2521-1", "marketing_start_date": "20111018"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (60505-2521-3)", "package_ndc": "60505-2521-3", "marketing_start_date": "20111018"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (60505-2521-8)", "package_ndc": "60505-2521-8", "marketing_start_date": "20111018"}], "brand_name": "cilostazol", "product_id": "60505-2521_855689c6-1a9b-a366-dcc4-e6a1c04ff25a", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "60505-2521", "generic_name": "cilostazol", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "50 mg/1"}], "application_number": "ANDA077030", "marketing_category": "ANDA", "marketing_start_date": "20111018", "listing_expiration_date": "20261231"}